Susan O’Connell, Consultant Paediatric Endocrinologist, Children’s Health Ireland; Incoming Paediatric Chair and Vice-Coordinator Endo-ERN
Professor Susan O’Connell is a Consultant Paediatric Endocrinologist at Children’s Health
Ireland (CHI) and Clinical Associate Professor at RCSI University of Medicine and Health
Sciences. She graduated from University College Dublin (UCD), completed her doctorate at
Trinity College Dublin (TCD), and undertook an international fellowship in Western Australia.
Since returning to Ireland in 2012, she has been actively involved in advancing rare disease care,
research and policy at national and European levels. She was a member of Ireland’s National
Clinical Programme for Rare Diseases from 2013 and chaired the working group responsible for
the HSE’s Model of Care for Transition from Paediatric to Adult Healthcare Providers in Rare
Diseases (2018).
Susan has served as Paediatric Lead for Ireland within the European Reference Network on Rare
Endocrine Conditions (ENDO-ERN) since 2022 and was recently elected Paediatric Chair of
ENDO-ERN, a role she will formally assume in April 2027.
Her clinical and research interests include improving transition of care, international rare disease
registries and collaborative research. She is a co-investigator in the HRB/EU-funded Rare
Disease Research Catalyst (RD CAT), supporting Ireland’s rare disease research capacity and
engagement with European initiatives, including the European Rare Diseases Research Alliance
(ERDERA).
Through her work within ENDO-ERN, she is committed to strengthening European
collaboration in rare disease research, education and training, and improving equitable access to
specialist expertise and innovative therapies. She recognises the central importance of
meaningful patient and public involvement in shaping research priorities, informing service
development and ensuring that advances in rare disease care reflect the needs and experiences of
patients and families.
She sees Ireland’s Presidency of the Council of the European Union as an important opportunity
to celebrate progress, showcase Ireland’s contribution and strengthen European partnerships,
bringing together clinicians, researchers, patients and patient organisations to translate shared
expertise and innovation into meaningful improvements in care and outcomes for people living
with rare diseases across Europe.